Astrazeneca Pharma India Ltd

₹6,254.35▼ -0.53%29 Sept

📊 Stock Analysis

Market Data

Market Cap₹15,635.88 Cr.

52W High₹9,850

Current Price₹6,254.35

52W Low₹6,217.5

Down from 52W High36.5 %

Face Value₹2

Performance

ROCE26.81 %

ROE19.43 %

EPS (TTM)₹15.17

EPS Prev Qtr₹17.95

EPS Last Year₹21.69

EBITDA Qtr₹43.71 Cr.

Book Value₹349

Financial Health

Debt/Equity0

Debt/Profit0

Total Assets₹1,989.1 Cr.

Dividend Yield0.58 %

Promoter Holding75 %

Earning Power10.69 %

Valuation

Stock P/E92.18

Industry P/E33.3

Price to Book17.91

Price to Sales6.43

Graham Number₹730.15

Key Metrics

Face Value

₹2

About Astrazeneca Pharma India Ltd

Healthcare · Pharmaceuticals

Astrazeneca Pharma India Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹2. Market cap ₹15,635.88 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.9	₹4,46,276.3 Cr	0.86%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	85.97	₹2,51,531.48 Cr	0.32%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	78.4	₹1,86,956.51 Cr	0.77%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	26.64	₹1,19,221.66 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.13	₹1,11,725.01 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	98.01	₹1,07,271.96 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Mankind Pharma Ltd	-	51.42	₹1,05,107.48 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Dr Reddys Laboratories Ltd	-	32.31	₹1,04,334.48 Cr	0.64%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Aurobindo Pharma Ltd	-	26.61	₹97,986.86 Cr	0.23%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.63	₹94,189.9 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	37.59	₹67,587.09 Cr	0.1%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	29.02	₹62,609.02 Cr	1.01%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	111.18	₹61,602.44 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.88	₹57,939.73 Cr	1.74%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Gland Pharma Ltd	-	43.62	₹49,299.85 Cr	0.67%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ipca Laboratories Ltd	-	36.55	₹49,280.78 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	85	₹49,084.9 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Glaxosmithkline Pharmaceuticals Ltd	-	44.95	₹47,217.7 Cr	2.05%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ajanta Pharma Ltd	-	39.17	₹44,452.1 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	559.09	611.57	578.61	682.79
↳ QoQ Growth	-	+9.4%	-5.4%	+18.0%
Expenses	486.48	570.58	523.3	639.08
Operating Profit	72.61	40.99	55.31	43.71
OPM %	12.99%	6.7%	9.56%	6.4%
Other Income	6.17	5.13	5.95	9.23
Interest	0.67	1.06	2.04	1.95
Depreciation	2.57	3.84	5.6	5.23
EBITDA	75.18	44.83	60.91	48.94
EBITDA Margin %	13.45%	7.33%	10.53%	7.17%
Profit Before Tax	72.82	46.54	58.14	50.75
Tax %	25.54%	29.97%	22.81%	25.26%
Net Profit	54.22	32.59	44.88	37.93
↳ QoQ Growth	-	-39.9%	+37.7%	-15.5%
EPS	21.69	13.04	17.95	15.17

Balance Sheet

	Mar 2025	Mar 2026
Equity Capital	5	5
Reserves	765.35	867.79
Borrowings	35.73	0
Other Liabilities	712.04	1116.31
Total Liabilities	1518.12	1989.1
Fixed Assets	63.58	117.47
CWIP	0	0
Investments	0	0
Other Assets	1454.54	1871.63
Total Assets	1518.12	1989.1

Cash Flows

	Mar 2026
Cash from Operating Activity	-15.14
Cash from Investing Activity	18.69
Cash from Financing Activity	-91.97
Net Cash Flow	-88.42

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	75%	75%	75%	75%
FIIs %	2.74%	2.71%	2.78%	2.68%
DIIs %	5.26%	5.56%	5.79%	6.08%
Public %	14.39%	14.14%	13.88%	13.76%
No. of Shareholders	32,914	31,551	29,007	29,338

Major Shareholders (>1%)

As of 2026-06-30View all shareholders →

Tools